171 related articles for article (PubMed ID: 36081668)
1. Dysregulation of Pseudogenes/lncRNA-Hsa-miR-1-3p-PAICS Pathway Promotes the Development of NSCLC.
Song Y; Wang Z; He L; Sun F; Zhang B; Wang F
J Oncol; 2022; 2022():4714931. PubMed ID: 36081668
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer.
Lou W; Ding B; Zhong G; Du C; Fan W; Fu P
Aging (Albany NY); 2019 Dec; 11(23):11416-11439. PubMed ID: 31794425
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
[TBL] [Abstract][Full Text] [Related]
4. A Next-Generation Sequencing of Plasma Exosome-Derived microRNAs and Target Gene Analysis with a Microarray Database of Thermally Injured Skins: Identification of Blood-to-Tissue Interactions at Early Burn Stage.
Li SJ; Cai ZW; Yang HF; Tang XD; Fang X; Qiu L; Wang F; Chen XL
J Inflamm Res; 2021; 14():6783-6798. PubMed ID: 34916825
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with prognosis of pancreatic cancer using bioinformatics analysis.
Jing S; Tian J; Zhang Y; Chen X; Zheng S
Aging (Albany NY); 2020 Oct; 12(19):19107-19128. PubMed ID: 33027767
[TBL] [Abstract][Full Text] [Related]
6. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
8. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
9. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
10. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
11. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
13. Regulating COX10-AS1 / miR-142-5p / PAICS axis inhibits the proliferation of non-small cell lung cancer.
Tang X; Wu Y; Yang J; Zhu W
Bioengineered; 2021 Dec; 12(1):4643-4653. PubMed ID: 34323174
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis.
Ren ZJ; Zhao Y; Wang G; Miao LL; Zhang ZC; Ma L; Teng MZ; Li YM
Clin Chim Acta; 2022 Jun; 531():25-35. PubMed ID: 35300960
[TBL] [Abstract][Full Text] [Related]
15. [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].
Ye J; Xu W; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):45-54. PubMed ID: 35249869
[TBL] [Abstract][Full Text] [Related]
16. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
18. Genome-scale CRISPR-Cas9 screen identifies
Li Y; Zhu L; Mao J; Zheng H; Hu Z; Yang S; Mao T; Zhou T; Cao P; Wu H; Wang X; Wang J; Lin F; Shen H
MedComm (2020); 2024 Mar; 5(3):e483. PubMed ID: 38463398
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
Chen J; Lou W; Ding B; Wang X
Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
[TBL] [Abstract][Full Text] [Related]
20. The Role of lncRNA
Chen W; Fan D; Guo B; Liu S; Li Z; Duan J; Fang C; Liu Y; Chen L
Ann Clin Lab Sci; 2022 Mar; 52(2):292-300. PubMed ID: 35414508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
